Siddiqi S M, Chen X, Schneller S W, Ikeda S, Snoeck R, Andrei G, Balzarini J, De Clercq E
Department of Chemistry, University of South Florida, Tampa 33620-5250.
J Med Chem. 1994 Feb 18;37(4):551-4. doi: 10.1021/jm00030a014.
In order to determine if the potent antiviral properties of (+/-)-5'-noraristeromycin reside in one of its enantiomers, an analysis of each enantiomer has been carried out. A five-step route to the (+)-stereoisomer is described from (+)-(1R,4S)-4-hydroxy-2-cyclopenten-1-yl acetate, whereas the synthesis of the (-)-enantiomer had been reported previously from the same starting material. The (-)-2 and (+)-2 enantiomers were evaluated for antiviral activity against a large number of viruses and found to display an antiviral activity spectrum characteristic of (S)-adenosyl-L-homocysteine hydrolase inhibitors. The (-)-enantiomer retained the significant anticytomegalovirus properties previously reported for the racemic 2 and was, on the average, 10-fold more potent than (+)-2 in inhibiting virus replication, tumor cell growth, and (S)-adenosyl-L-homocysteine hydrolase activity.
为了确定(±)-5'-去甲阿瑞吡坦的强效抗病毒特性是否存在于其对映体之一中,已对每种对映体进行了分析。从(+)-(1R,4S)-4-羟基-2-环戊烯-1-基乙酸酯描述了一条合成(+)-立体异构体的五步路线,而(-)-对映体的合成先前已报道是从相同的起始原料开始。对(-)-2和(+)-2对映体针对大量病毒的抗病毒活性进行了评估,发现它们显示出(S)-腺苷-L-高半胱氨酸水解酶抑制剂的抗病毒活性谱特征。(-)-对映体保留了先前报道的外消旋体2的显著抗巨细胞病毒特性,并且在抑制病毒复制、肿瘤细胞生长和(S)-腺苷-L-高半胱氨酸水解酶活性方面,平均比(+)-2强10倍。